PDS Biotechnology Corporation (PDSB) Capital expenditures 2013–2025
PDS Biotechnology Corporation (PDSB) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2013: $136,894 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $29,000 | — |
| FY2023 | $0 | — |
| FY2018 | $0 | -100.0% |
| FY2017 | $188,721 | -72.5% |
| FY2016 | $686,705 | -47.4% |
| FY2015 | $1.3M | +47.5% |
| FY2014 | $884,793 | +546.3% |
| FY2013 | $136,894 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice